Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Pediatric contributions and lessons learned from the NEPTUNE cohort study
for the NEPTUNE investigators
Division of Anatomic and Molecular Pathology (AMP)
Department of Pediatrics
Division of Nephrology, Hypertension & Apheresis
Institute of Clinical and Translational Sciences (ICTS)
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pediatric contributions and lessons learned from the NEPTUNE cohort study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pediatric
100%
Lessons Learned
100%
Neptune
100%
All Ages
40%
Primary Glomerulonephritis
40%
Pathological Features
20%
Pediatric Patients
20%
Clinical Data
20%
Genomic Data
20%
Effective Therapy
20%
Molecular Characterization
20%
Precision Medicine
20%
Demographic Data
20%
Longitudinal Cohort Study
20%
Glomerular Disease
20%
Pathobiology
20%
Non-invasive Biomarkers
20%
Transcriptomic Data
20%
Clinical Trial Participation
20%
Biomarker Profile
20%
Metabolomics Data
20%
Safe Therapy
20%
Molecular Classification
20%
Feature-based
20%
Focal Segmental Glomerulosclerosis
20%
Minimal Change Disease
20%
Membranous Nephropathy
20%
Multi-scalar
20%
Rare Cancer Network
20%
Medicine and Dentistry
Pediatrics
100%
Cohort Analysis
100%
Glomerulopathy
100%
Biological Marker
33%
Clinical Trial
33%
Pediatrics Patient
33%
Personalized Medicine
33%
Disease
33%
Rare Disease
33%
Transcriptomics
33%
Metabolomics
33%
Minimal Change Disease
33%
Focal Segmental Glomerulosclerosis
33%
Membranous Glomerulonephritis
33%
Molecular Classification
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Glomerulopathy
100%
Clinical Trial
33%
Biological Marker
33%
Rare Disease
33%
Focal Glomerulosclerosis
33%
Membranous Glomerulonephritis
33%
Diseases
33%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Clinical Trial
50%
Metabolomics
50%
Transcriptomics
50%
Focal Segmental Glomerulosclerosis
50%
Genomics
50%